The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease
Open accessAbstract
Cardiovascular problems are a major cause of morbidity and mortality in patients with autosomal-dominant polycystic kidney disease (ADPKD). Hypertension is a common early symptom of ADPKD, and occurs in approximately 60% of patients before renal function has become impaired. Hypertension is associated with an increased rate of progression to end-stage renal disease and is the most important potentially treatable variable in ADPKD. Left ventricular hypertrophy, which is a powerful, independent risk factor for cardiovascular morbidity and mortality, also occurs frequently in patients with ADPKD. Both hypertension and left ventricular hypertrophy have important roles in cardiovascular complications in these individuals. Moreover, biventricular diastolic dysfunction, endothelial dysfunction, increased carotid intima–media thickness, and impaired coronary flow velocity reserve are present even in young patients with ADPKD who have normal blood pressure and well-preserved renal function. These findings suggest that cardiovascular involvement starts very early in the course of ADPKD. Intracranial and extracranial aneurysms and cardiac valvular defects are other potential cardiovascular problems in patients with ADPKD. Early diagnosis and treatment of hypertension, with drugs that block the renin–angiotensin–aldosterone system, has the potential to decrease the cardiovascular complications and slow the progression of renal disease in ADPKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Koren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D., & Laragh, J. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-5-345 · Cited by 2,366
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.
Verdecchia, P., Schillaci, G., Guerrieri, M., Gatteschi, C., Benemio, G., Boldrini, F., & Porcellati, C. (1990) · Circulation · doi:10.1161/01.cir.81.2.528 · Cited by 1,224
Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease
Gabow, P. A., Johnson, A. M., Kaehny, W. D., Kimberling, W. J., Lezotte, D. C., Duley, I. T., & Jones, R. H. (1992) · Kidney International · doi:10.1038/ki.1992.195 · Cited by 509
The Renin–Angiotensin–Aldosterone System and Autosomal Dominant Polycystic Kidney Disease
Chapman, A. B., Johnson, A., Gabow, P. A., & Schrier, R. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231602 · Cited by 398
Self-citationDiseases of the kidney and urinary tract
Schrier, R. W. (2001) · Cited by 396
Self-citationCauses of death in autosomal dominant polycystic kidney disease.
Fick, G. M., Johnson, A. M., Hammond, W. S., & Gabow, P. A. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122048 · Cited by 342
Lembo, G., Napoli, R., Capaldo, B., Rendina, V, Iaccarino, G., Volpe, M., Trimarco, B., & Saccà, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115842 · Cited by 252
Klahr, S., Breyer, J. A., Beck, G. J., Dennis, V. W., Hartman, J. A., Roth, D., Steinman, T. I., Wang, S. R., & Yamamoto, M. E. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122037 · Cited by 251
Sympathetic Activity Is Increased in Polycystic Kidney Disease and Is Associated with Hypertension
KLEIN, I. H. H. T., LIGTENBERG, G., OEY, P. L., KOOMANS, H. A., & BLANKESTIJN, P. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112427 · Cited by 248
Diseases of the kidney and urinary tract
Edelmann, C. M., & Bernstein, J. (1992) · Medical Entomology and Zoology · Cited by 235
Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.
Chapman, A. B., Johnson, A. M., Gabow, P. A., & Schrier, R. W. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v561349 · Cited by 235
Self-citationVascular expression of polycystin.
Griffin, M. D., Torres, V. E., Grande, J. P., & Kumar, R. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v84616 · Cited by 234
Echocardiographic Findings in Autosomal Dominant Polycystic Kidney Disease
Hossack, K. F., Leddy, C. L., Johnson, A. M., Schrier, R. W., & Gabow, P. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810063191404 · Cited by 225
Self-citationRenal structure and hypertension in autosomal dominant polycystic kidney disease
Gabow, P. A., Chapman, A. B., Johnson, A. M., Tangel, D. J., Duley, I. T., Kaehny, W. D., Manco-Johnson, M., & Schrier, R. W. (1990) · Kidney International · doi:10.1038/ki.1990.330 · Cited by 225
Self-citationHypertension in Autosomal-Dominant Polycystic Kidney Disease: Early Occurrence and Unique Aspects
ECDER, T., & SCHRIER, R. W. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v121194 · Cited by 205
Self-citationSchrier, R., McFann, K., Johnson, A., Chapman, A., Edelstein, C., Brosnahan, G., Ecder, T., & Tison, L. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018407.60002.b9 · Cited by 200
Self-citationLeft ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman, A. B., Johnson, A. M., Rainguet, S., Hossack, K., Gabow, P., & Schrier, R. W. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v881292 · Cited by 180
Self-citationCardiovascular Abnormalities Associated with Adult Polycystic Kidney Disease
LEIER, C. V., BAKER, P. B., KILMAN, J. W., & WOOLEY, C. F. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-683 · Cited by 160
Schrier, R. W. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080882 · Cited by 157
Self-citationWang, D., Iversen, J., Wilcox, C. S., & Strandgaard, S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00236.x · Cited by 156
The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease
Loghman‐Adham, M., Soto, C. E., Inagami, T., & Cassis, L. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00370.2003 · Cited by 155
Autosomal dominant polycystic kidney disease in childhood: A longitudinal study
Sedman, A. B., Bell, P., Manco‐Johnson, M. J., Schrier, R. W., Warady, B. A., Heard, E. O., Butler–Simon, N., & Gabow, P. A. (1987) · Kidney International · doi:10.1038/ki.1987.98 · Cited by 151
Self-citationKelleher, C. L., McFann, K. K., JOHNSON, A., & Schrier, R. W. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.06.020 · Cited by 140
Self-citationEcder, T., Chapman, A. B., Brosnahan, G., Edelstein, C. L., Johnson, A. M., & Schrier, R. W. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70195-8 · Cited by 138
Self-citationSynthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease
Torres, V. E., Donovan, K. A., Scicli, G. M., Holley, K. E., Thibodeau, S. N., Carretero, O. A., Inagami, T., McAteer, J. A., & Johnson, C. M. (1992) · Kidney International · doi:10.1038/ki.1992.297 · Cited by 138
Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease
Schrier, R. W., McFann, K. K., & Johnson, A. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00776.x · Cited by 136
Self-citationChapman, A. B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00060108 · Cited by 128
Lumiaho, A., Ikäheimo, R., Miettinen, R., Niemitukia, L. H., Laitinen, T., Rantala, A., Lampainen, E., Laakso, M., & Hartikainen, J. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.29216 · Cited by 123
The anatomy of the renin-secreting cell in adult polycystic kidney disease
Graham, P., & Lindop, G. B. M. (1988) · Kidney International · doi:10.1038/ki.1988.115 · Cited by 121
Vascular Expression of Polycystin-2
Torres, V. E., CAI, Y., CHEN, X., WU, G. Q., GENG, L., CLEGHORN, K. A., JOHNSON, C. M., & Somlo, S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1211 · Cited by 119
Cadnapaphornchai, M. A., McFann, K., Strain, J. D., Masoumi, A., & Schrier, R. W. (2008) · Kidney International · doi:10.1038/ki.2008.397 · Cited by 118
Self-citationKocaman, O., Oflaz, H., Yekeler, E., Dursun, M., Erdoğan, D., Demirel, Ş., Alışır, S., Turgut, F. H., Mercanoğlu, F., & Ecder, T. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.01.011 · Cited by 112
Self-citationHyperinsulinemia and the aldosterone and pressor responses to angiotensin II.
Rocchini, A. P., Moorehead, C., DeRemer, S. J., Goodfriend, T. L., & Ball, D. L. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.861 · Cited by 112
Ecder, T., Edelstein, C. L., Fick-Brosnahan, G. M., Johnson, A. M., Chapman, A. B., Gabow, P. A., & Schrier, R. W. (2001) · American Journal of Nephrology · doi:10.1159/000046231 · Cited by 109
Self-citationHarrap, S. B., Davies, D. L., Macnicol, A. M., Dominiczak, A. F., Fraser, R., Wright, A. F., Watson, M. L., & Briggs, J. D. (1991) · Kidney International · doi:10.1038/ki.1991.238 · Cited by 105
Role of vasopressin in essential hypertension
Bakris, G. L., Bursztyn, M., Gavras, I., Bresnahan, M. R., & Gavras, H. P. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715050-00011 · Cited by 105
Jafar, T. H., Stark, P. C., Schmid, C. H., Strandgaard, S., Kamper, A., Maschio, G., Becker, G. J., Perrone, R. D., & Levey, A. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00077.x · Cited by 101
Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
Chapman, A. B., & Schrier, R. W. (1991) · PubMed · Cited by 97
Self-citationGharavi, A. G., Lipkowitz, M. S., Diamond, J. A., Jhang, J. S., & Phillips, R. A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00198-1 · Cited by 96
Baboolal, K., Ravine, D., Daniels, J., Williams, N., Holmans, P., Coles, G. A., & Williams, J. D. (1997) · Kidney International · doi:10.1038/ki.1997.373 · Cited by 92
Wang, D., Strandgaard, S., Børresen, M. L., Luo, Z., Connors, S. G., Yan, Q., & Wilcox, C. S. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.09.020 · Cited by 89
No effect of enalapril on progression in autosomal dominant polycystic kidney disease
van Dijk, M. A., Breuning, M. H., Duiser, R., van Es, L. A., & Westendorp, R. G. J. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg417 · Cited by 86
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease
Belz, M. M., Fick-Brosnahan, G. M., Hughes, R. L., Rubinstein, D., Chapman, A. B., Johnson, A. M., Mcfann, K. K., Kaehny, W. D., & Gabow, P. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00918.x · Cited by 84
Barrett, B. J., Foley, R. N., Morgan, J. M., Hefferton, D., & Parfrey, P. S. (1994) · Kidney International · doi:10.1038/ki.1994.374 · Cited by 81
Insulin resistance in adult polycystic kidney disease
Vareesangthip, K., Tong, P. C. Y., Wilkinson, R., et al. (1997) · Kidney International · doi:10.1038/ki.1997.360 · Cited by 79
Belz, M. M., Hughes, R. L., Kaehny, W. D., et al. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27694 · Cited by 77
Nutahara, K., Higashihara, E., Horie, S., Kamura, K., Tsuchiya, K., Mochizuki, T., Hosoya, T., Nakayama, T., Yamamoto, N., Higaki, Y., et al. (2005) · Nephron Clinical Practice · doi:10.1159/000081790 · Cited by 77
Bardajı́, A., Vea, A. M., Gutiérrez, C., Ridao, C., Richart, C., & Oliver, J. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70071-x · Cited by 75
Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease
Watson, M. L., Macnicol, A. M., Allan, P. L., & Wright, A. F. (1992) · Kidney International · doi:10.1038/ki.1992.28 · Cited by 74
Torres, V. E., Wilson, D. M., Burnett, J. C. J., JOHNSON, C. M., & Offord, K. P. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61724-8 · Cited by 74
Schrier, R. W., Belz, M. M., Johnson, A. M., Kaehny, W. D., Hughes, R. L., Rubinstein, D., & Gabow, P. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000118527.74850.66 · Cited by 74
Self-citationPérez-Oller, L., Torrá, R., Bádenas, C., Milà, M., & Darnell, A. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70355-0 · Cited by 71
Vasopressin Antagonists in Polycystic Kidney Disease
Torres, V. E. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2008.03.003 · Cited by 70
Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease
Graf, S. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.5.819 · Cited by 69
Relation among Left Ventricular Mass, Insulin Resistance, and Blood Pressure in Nonobese Subjects1
Phillips, R. A., Krakoff, L. R., Dunaif, A. E., Finegood, D. T., Gorlin, R., & Shimabukuro, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5331 · Cited by 67
Doulton, T. W. R., Saggar-Malik, A. K., He, F. J., Carney, C., Markandu, N. D., Sagnella, G. A., & MacGregor, G. A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222765.30348.0d · Cited by 63
Hyperinsulinemia and Left Ventricular Geometry in a Work-Site Population in Japan
Ohya, Y., Abe, I., Fujii, K., Ohmori, S., Onaka, U., Kobayashi, K., & Fujishima, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.729 · Cited by 62
Vasopressin antagonists in polycystic kidney disease
Torres, V. E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00703.x · Cited by 61
Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease
Oflaz, H., Alışır, S., Büyükaydın, B., Kocaman, O., Turgut, F. H., Namli, Ş., Pamukçu, B., Öncül, A., & Ecder, T. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00682.x · Cited by 61
Self-citationEcder, T. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.5.1113 · Cited by 61
Self-citationMunemura, C., Uemasu, J., & Kawasaki, H. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80212-5 · Cited by 60
Zeltner, R., Poliak, R., Stiasny, B., Schmieder, R. E., & Schulze, B. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm731 · Cited by 54
Steinman, T. I. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm865 · Cited by 52
Türkmen, K., Oflaz, H., Uslu, B., Çimen, A. O., Elitok, A., Kaşıkçıoğlu, E., Alışır, S., Tufan, F., Namli, Ş., Uysal, M., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02330607 · Cited by 49
Self-citationBørresen, M. L., Wang, D., & Strandgaard, S. (2007) · American Journal of Nephrology · doi:10.1159/000101369 · Cited by 48
Endothelial-derived vasoactive mediators in polycystic kidney disease
Alnimri, M., Komers, R., Oyama, T., Subramanya, A. R., Lindsley, J. N., & Anderson, S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00913.x · Cited by 46
Fernandes, S., Bruneval, P., Hagège, A. A., Heudes, D., Ghostine, S., & Bouby, N. (2002) · Endocrinology · doi:10.1210/endo.143.7.8918 · Cited by 42
Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease
Wa, T. C. L. K., Macnicol, A. M., & Watson, M. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.10.2075 · Cited by 36
Lumiaho, A., Pihlajamäki, J., Hartikainen, J. E. K., Ikäheimo, R., Miettinen, R., Niemitukia, L. H., Lampainen, E., & Laakso, M. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00354-8 · Cited by 33
Natriuretic Response to Volume Expansion in Polycystic Kidney Disease
Torres, V. E., Wilson, D. M., Offord, K. P., Burnett, J. C. J., & Romero, J. C. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65554-2 · Cited by 30
Estacio, R. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00013-8 · Cited by 29
van Dijk, M. A., Breuning, M. H., Peters, D. J. M., & Chang, P. C. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.6.836 · Cited by 26
Ecder, T., McFann, K. K., Raynolds, M. V., & Schrier, R. W. (2003) · American Journal of Nephrology · doi:10.1159/000074653 · Cited by 19
Self-citation
Cited by
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Autosomal dominant polycystic kidney disease: the changing face of clinical management
Ong, A. C. M., Devuyst, O., Knebelmann, B., & Walz, G. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60907-2 · Cited by 280
Kou, P., Wei, S., & Xiong, F. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180330094434 · Cited by 6
Metadata
- Authors
- Ecder, T., & Schrier, R. W.
- Venue
- Nature Reviews Nephrology
- Published
- 2009-04
- Volume
- 5
- Issue
- 4
- Pages
- 221-228
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2030927065
- Cited by
- 275
- References
- 74
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.